Not provided
Not provided
Not provided
Not provided
Enrollment Difficulties
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study is being conducted to see how safe and effective the Prevena Incision Management System "Prevena" is when placed over a renal transplantation incision. Prevena provides negative pressure (suction) wound therapy. Prevena will be tested while applied during the time each subject is hospitalized and up to 5 days after the surgery. Prevena is a small portable negative pressure device which consists of a therapy unit that delivers negative pressure. It also includes a dressing system that is intended for use over closed incisions after surgery.
The intent of this study is to evaluate Prevena versus the standard care that a doctor would use normally after a kidney transplant.
This is a randomized, single-center, comparative interventional study looking at the effect of Prevenaâ„¢ on renal transplant surgical Subjects compared to a control arm treated with the standard-of-care wound dressing. The prospective, post-marketing clinical study described in this protocol will assess the effectiveness and functional performance of PrevenaTM in this clinical indication.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Prevena Incision Management System | Experimental | Negative Pressure Therapy Device |
|
| Standard of Care for Surgical Incisions | Placebo Comparator | Sterile gauze and a non-penetrable barrier |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Prevena Incision Management System | Device | It is intended to manage the environment of surgical incisions that continue to drain following sutured or stapled closure by maintaining a closed environment and removing exudate via the application of negative pressure wound therapy (NPWT). |
| Measure | Description | Time Frame |
|---|---|---|
| Number of Participants With Surgical Site Complications (SSCs) | The primary objective to compare short-term surgical incision-related clinical outcomes in Subjects undergoing open renal transplant surgery when treated with Prevena vs. the standard-of-care wound dressing. Clinical outcomes of interest are defined as Surgical Site Complications (SSCs) that include incisional fluid accumulation (i.e. seroma, hematoma, abscess), dehiscence, surgical site infection (SSI). These outcomes will be compared to a control group consisting of subjects screened for the same inclusion/exclusion criteria but treated with standard-of-care incision dressing. | 62 Days |
Not provided
Not provided
Pre-operative Inclusion Criteria
The Subject:
is an adult ≥ 18 years old of either gender
is able to provide their own informed consent Protocol: AHS.2012.Prevena.Cooper.01 v 4.0 Confidential/Property of KCI USA, Inc. Page 6 of 71
will undergo open renal transplant surgery within the next 30 days
will require a surgical incision able to be covered completely by the PIMS dressing
is pre-operatively assessed to undergo a procedure with a CDC Wound Classification of:
Class I (Clean): An uninfected operative wound in which no inflammation is encountered and the respiratory, alimentary, genital, or uninfected urinary tract is not entered
- OR -
Class II (Clean Contaminated): An operative wound in which the respiratory, alimentary, genital, or uninfected urinary tract are entered under controlled conditions and without unusual contamination
is willing and able to return for all scheduled and required study visits
if female, must test negative on serum pregnancy test
if a female of child-bearing potential, must be willing to utilize an acceptable method of birth control (e.g., birth control pills, condom with spermicide, diaphragm with spermicide, implants, IUD, injections, vaginal rings, hormonal skin patch, etc.) for the duration of study participation
is not concurrently enrolled in a clinical trial which may impact subject health or the surgical incision site
Intra-operative Inclusion Criteria Subjects must meet the following intra-operative inclusion criteria to be eligible for randomization.
The Subject:
Pre-operative Exclusion Criteria
The Subject:
has a BMI < 18.5 kg/m2 and > 40 kg/m2
has a systemic infection at the time of open renal transplant surgery
has a remote-site skin infection at the time of open renal transplant surgery
is preoperatively assessed to undergo a procedure with a CDC Wound Classification of:
Class III (Contaminated): Open, fresh, accidental wounds, and/or major breaks in sterile technique or gross spillage from the gastrointestinal tract
- OR -
Class IV (Dirty-Infected): Old traumatic wounds with retained devitalized tissue and those that involve existing clinical infection or perforated viscera
has a known allergy or hypersensitivity to silver, or drape materials that contain acrylic adhesives
Intra-Operative Exclusion Criteria Subjects who meet any of the following intra-operative exclusion criteria are considered screen failures and are not eligible for randomization.
The Subject:
is found to meet any of the pre-operative exclusion criteria
has obvious contamination of the surgical incision
requires external surgical drains that will be covered by the PIMS dressing
is determined to have a CDC Wound Classification of:
Class III (Contaminated): Open, fresh, accidental wounds, and/or major breaks in sterile technique or gross spillage from the gastrointestinal tract
- OR -
Class IV (Dirty-Infected): Old traumatic wounds with retained devitalized tissue and those that involve existing clinical infection or perforated viscera Protocol: AHS.2012.Prevena.Cooper.01 v 4.0 Confidential/Property of KCI USA, Inc. Page 8 of 71
requires a transfusion, has disseminated-intravascular coagulopathy (DIC) or other medical or surgical conditions during open renal transplant surgery deemed by the Investigator to pose a prohibitively high risk for surgical re-exploration
is deemed unable to continue in the study by the Investigator as the Subject's safety or well-being may be jeopardized.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Matthew Cooper, MD | MedStar Georgetown University Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| MedStar Georgetown University Hospital | Washington D.C. | District of Columbia | 20007 | United States |
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Prevena Incision Management System | Negative Pressure Therapy Device Prevena Incision Management System: It is intended to manage the environment of surgical incisions that continue to drain following sutured or stapled closure by maintaining a closed environment and removing exudate via the application of negative pressure wound therapy (NPWT). |
| FG001 | Standard of Care for Surgical Incisions | Sterile gauze and a non-penetrable barrier Standard of Care for Surgical Incisions: Sterile 4X4 Non-Penetrable barrier |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Prevena Incision Management System | Negative Pressure Therapy Device Prevena Incision Management System: It is intended to manage the environment of surgical incisions that continue to drain following sutured or stapled closure by maintaining a closed environment and removing exudate via the application of negative pressure wound therapy (NPWT). |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Number of Participants With Surgical Site Complications (SSCs) | The primary objective to compare short-term surgical incision-related clinical outcomes in Subjects undergoing open renal transplant surgery when treated with Prevena vs. the standard-of-care wound dressing. Clinical outcomes of interest are defined as Surgical Site Complications (SSCs) that include incisional fluid accumulation (i.e. seroma, hematoma, abscess), dehiscence, surgical site infection (SSI). These outcomes will be compared to a control group consisting of subjects screened for the same inclusion/exclusion criteria but treated with standard-of-care incision dressing. | Analysis of this endpoint was based on the Full analysis Set (FAS population). The FAS population consists of participants who met all of the pre- and intra-operative eligibility criteria, were randomized and received treatment. Subjects without SSC must have received 5 days of Prevena or at least 3 days of SOC dressing and completed 30 day visit. | Posted | Count of Participants | Participants | 62 Days |
|
Not provided
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Prevena Incision Management System | Negative Pressure Therapy Device Prevena Incision Management System: It is intended to manage the environment of surgical incisions that continue to drain following sutured or stapled closure by maintaining a closed environment and removing exudate via the application of negative pressure wound therapy (NPWT). |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Wound Dehiscence | Injury, poisoning and procedural complications | Systematic Assessment |
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Dr. Matthew Cooper | Medstar Georgetown University Hospital | 202-444-0753 | Matthew.Cooper@gunet.georgetown.edu |
Not provided
| ID | Term |
|---|---|
| D059039 | Standard of Care |
| ID | Term |
|---|---|
| D019984 | Quality Indicators, Health Care |
| D011787 | Quality of Health Care |
| D006298 | Health Services Administration |
| D017530 | Health Care Quality, Access, and Evaluation |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Standard of Care for Surgical Incisions | Other | Sterile 4X4 Non-Penetrable barrier |
|
| BG001 |
| Standard of Care for Surgical Incisions |
Sterile gauze and a non-penetrable barrier Standard of Care for Surgical Incisions: Sterile 4X4 Non-Penetrable barrier |
| BG002 | Total | Total of all reporting groups |
| years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Ethnicity (NIH/OMB) | Count of Participants | Participants |
|
| Race (NIH/OMB) | Count of Participants | Participants |
|
| OG000 |
| Prevena Incision Management System |
Negative Pressure Therapy Device Prevena Incision Management System: It is intended to manage the environment of surgical incisions that continue to drain following sutured or stapled closure by maintaining a closed environment and removing exudate via the application of negative pressure wound therapy (NPWT). |
| OG001 | Standard of Care for Surgical Incisions | Sterile gauze and a non-penetrable barrier Standard of Care for Surgical Incisions: Sterile 4X4 Non-Penetrable barrier |
|
|
| 11 |
| 31 |
| 0 |
| 31 |
| EG001 | Standard of Care for Surgical Incisions | Sterile gauze and a non-penetrable barrier Standard of Care for Surgical Incisions: Sterile 4X4 Non-Penetrable barrier | 13 | 32 | 0 | 32 |
| Atrial Fibrillation | Cardiac disorders | Non-systematic Assessment |
|
| Myocardial Infarction | Cardiac disorders | Non-systematic Assessment |
|
| Chest Pain | General disorders | Non-systematic Assessment |
|
| Kidney Transplant Rejection | Immune system disorders | Non-systematic Assessment |
|
| Wound Infection | Infections and infestations | Systematic Assessment |
|
| Ankle Fracture | Injury, poisoning and procedural complications | Non-systematic Assessment |
|
| Complications of Transplanted Kidney | Injury, poisoning and procedural complications | Non-systematic Assessment |
|
| Fall | Injury, poisoning and procedural complications | Non-systematic Assessment |
|
| Post Procedural Haemorrhage | Injury, poisoning and procedural complications | Non-systematic Assessment |
|
| Blood Creatine Increased | Investigations | Non-systematic Assessment |
|
| Urine Output Decreased | Investigations | Non-systematic Assessment |
|
| Hypercreatininaemia | Metabolism and nutrition disorders | Non-systematic Assessment |
|
| Hyperkalaemia | Metabolism and nutrition disorders | Non-systematic Assessment |
|
| Pain in Extremity | Musculoskeletal and connective tissue disorders | Non-systematic Assessment |
|
| Cerebrovascular | Nervous system disorders | Non-systematic Assessment |
|
| Bronchospasm | Respiratory, thoracic and mediastinal disorders | Non-systematic Assessment |
|
| Dyspnoea | Respiratory, thoracic and mediastinal disorders | Non-systematic Assessment |
|
| Incisional Drainage | Surgical and medical procedures | Systematic Assessment |
|
| Ebolism | Vascular disorders | Non-systematic Assessment |
|
| Haematoma | Vascular disorders | Systematic Assessment |
|
| Haemorrhage | Vascular disorders | Non-systematic Assessment |
|
Not provided
Not provided